Dommershuijsen, Lisanne J. http://orcid.org/0000-0001-6951-6935
Darweesh, Sirwan K. L. http://orcid.org/0000-0002-4361-4593
Ben-Shlomo, Yoav
Kluger, Benzi M.
Bloem, Bastiaan R. http://orcid.org/0000-0002-6371-3337
Article History
Received: 13 March 2023
Accepted: 6 October 2023
First Online: 19 October 2023
Competing interests
: L.J. Dommershuijsen: None. S.K.L. Darweesh has received funding from the Parkinson’s Foundation(PF-FBS-2026), ZonMW (09150162010183), ParkinsonNL (P2022-07 and P2021-14), Michael J Fox Foundation (MJFF-022767)and Edmond J Safra Foundation. Y. Ben-Shlomo has received research support from the UK Medical Research Council, Wellcome Trust, NIHR, Parkinson’s UK, Versus Arthritis, Gatsby Foundation, Dunhill Trust. This work was facilitated by a Radboud University Excellence award. B.M. Kluger: None. B.R. Bloem currently serves as Editor in Chief for the Journal of Parkinson’s disease, serves on the editorial board of Practical Neurology and Digital Biomarkers, has received honoraria from serving on the scientific advisory board for Abbvie, Biogen and UCB, has received fees for speaking at conferences from AbbVie, Zambon, Roche, GE Healthcare and Bial, and has received research support from the Netherlands Organization for Scientific Research, the Michael J Fox Foundation, UCB, Abbvie, the Stichting Parkinson Fonds, the Hersenstichting Nederland, the Parkinson’s Foundation, Verily Life Sciences, Horizon 2020, the Topsector Life Sciences and Health, the Gatsby Foundation and the Parkinson Vereniging.